Sign in
4

Changes in Ownership

SAB Biotherapeutics, Inc. Filed Acc 0001193125-26-039564

Options or other derivatives

  • CEO acquired 4,800,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Reich Samuel J · CEO

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-02-03 Grant or award : show line 1 in the form Stock option (right to buy) +4,800,000 4,800,000 D
Loading xslF345X05/ownership.xml…